Javascript must be enabled to continue!
Barriers to viral load suppression among HIV-positive adolescents in antiretroviral therapy: a retrospective cohort study in Tanga, Tanzania
View through CrossRef
Abstract
Background: Despite lower rates of the human immunodeficiency virus (HIV) among adolescents in Tanzania, the number of adolescents living with HIV is increasing. Generally, adolescents are lagging in achieving the “Third 95” target that focuses on suppressing the viral load to 95% of those on treatment. This study aimed to describe factors independently associated with viral load non-suppression among HIV-positive ART-experienced adolescents in care and treatment health services facilities supported by Amref Health Africa Tanzania in the Tanga region.
Methods: A retrospective review of routinely collected HIV program records was carried out. We extracted data from the CTC2 database that included age, sex, BMI, WHO HIV staging, marital status, ART duration, VLS, regimen, facility level, and Dolutegravir (DTG)-based drug. Descriptive analysis using frequencies was carried out to describe the study participants' sociodemographic and clinical characteristics. Multiple logistic regression was done to adjust for factors associated with viral load non-suppression. Viral load non-suppression was defined as viral load ≥ 1000 copies/ml.
Results: 2493 (98%) adolescents were on first-line ART, and 2286 (89.68%) participants were virally suppressed, while 263 (10.32%) had viral load non-suppression (≥ 1000 copies/ml). In addition, 2322 (91.09%) of participants on ART were using DTD-related drugs; of them, 92.76% were virally suppressed. Not using DTG-related drugs (OR: 13.89, 95% CI 6.44 – 16.96) and hospital facility level (OR: 3.53, 95% CI 1.39 – 8.99) were independently associated with increased odds for not achieving viral load suppression. In addition, adolescents aged between 15 – 19 years were more likely associated with viral load suppression (OR: 0.54, 95% CI 0.30 – 0.97).
Conclusion: 10.32% of the adolescents on ART did not achieve viral load suppression, not using DTG-related drugs, and the hospital facility level increased the odds of not achieving viral load suppression. The use of DTG-related drugs significantly lowered viral load. HIV intervention strategies should be improved to ensure DTG utilisation in all PLHIV on ART and techniques used by health centres are disseminated to the hospital facility level.
Research Square Platform LLC
Title: Barriers to viral load suppression among HIV-positive adolescents in antiretroviral therapy: a retrospective cohort study in Tanga, Tanzania
Description:
Abstract
Background: Despite lower rates of the human immunodeficiency virus (HIV) among adolescents in Tanzania, the number of adolescents living with HIV is increasing.
Generally, adolescents are lagging in achieving the “Third 95” target that focuses on suppressing the viral load to 95% of those on treatment.
This study aimed to describe factors independently associated with viral load non-suppression among HIV-positive ART-experienced adolescents in care and treatment health services facilities supported by Amref Health Africa Tanzania in the Tanga region.
Methods: A retrospective review of routinely collected HIV program records was carried out.
We extracted data from the CTC2 database that included age, sex, BMI, WHO HIV staging, marital status, ART duration, VLS, regimen, facility level, and Dolutegravir (DTG)-based drug.
Descriptive analysis using frequencies was carried out to describe the study participants' sociodemographic and clinical characteristics.
Multiple logistic regression was done to adjust for factors associated with viral load non-suppression.
Viral load non-suppression was defined as viral load ≥ 1000 copies/ml.
Results: 2493 (98%) adolescents were on first-line ART, and 2286 (89.
68%) participants were virally suppressed, while 263 (10.
32%) had viral load non-suppression (≥ 1000 copies/ml).
In addition, 2322 (91.
09%) of participants on ART were using DTD-related drugs; of them, 92.
76% were virally suppressed.
Not using DTG-related drugs (OR: 13.
89, 95% CI 6.
44 – 16.
96) and hospital facility level (OR: 3.
53, 95% CI 1.
39 – 8.
99) were independently associated with increased odds for not achieving viral load suppression.
In addition, adolescents aged between 15 – 19 years were more likely associated with viral load suppression (OR: 0.
54, 95% CI 0.
30 – 0.
97).
Conclusion: 10.
32% of the adolescents on ART did not achieve viral load suppression, not using DTG-related drugs, and the hospital facility level increased the odds of not achieving viral load suppression.
The use of DTG-related drugs significantly lowered viral load.
HIV intervention strategies should be improved to ensure DTG utilisation in all PLHIV on ART and techniques used by health centres are disseminated to the hospital facility level.
Related Results
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract
Introduction
Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
A infecção pelo vírus do HIV pode ocorrer de diversas maneiras, tendo sua principal forma a via sexual por meio do sexo desprotegido. O vírus do HIV fica em um período de incubação...
Barriers to viral load suppression among adolescents living with HIV on anti-retroviral therapy: a retrospective study in Tanga, Tanzania
Barriers to viral load suppression among adolescents living with HIV on anti-retroviral therapy: a retrospective study in Tanga, Tanzania
Abstract
Background
Despite the decreased incidence of the human immunodeficiency virus (HIV) in Tanzania, the number of adolescents living with HIV...
Faktor Prediktor Kegagalan Virologis pada Pasien HIV yang Mendapat Terapi ARV Lini Pertama dengan Kepatuhan Berobat Baik
Faktor Prediktor Kegagalan Virologis pada Pasien HIV yang Mendapat Terapi ARV Lini Pertama dengan Kepatuhan Berobat Baik
Pendahuluan. Pada negara dengan keterbatasan sumber daya, pengukuran viral load (VL) sebagai prediktor efektivitas terapi antiretroviral (ARV) tidak selalu mudah untuk diakses oleh...
Treatment factors associated with viral suppression among adolescents on antiretroviral therapy in Kenya
Treatment factors associated with viral suppression among adolescents on antiretroviral therapy in Kenya
Background: There are approximately 99,159 adolescents living with human immunodeficiency virus in Kenya, with a viral suppression rate of 67%, according to the Joint United Nation...
Evaluasi Terapi Antiretroviral Pasien HIV/AIDS
Evaluasi Terapi Antiretroviral Pasien HIV/AIDS
Pengobatan antiretroviral (ARV) bertujuan untuk menurunkan jumlah virus (viral load) serta menghambat perburukan infeksi oportunistik. Ketidakrasionalan terapi ARV akan menyebabkan...
CD4+ T cell count and HIV-1 viral load dynamics positively impacted by H. pylori infection in HIV-positive patients regardless of ART status in a high-burden setting
CD4+ T cell count and HIV-1 viral load dynamics positively impacted by H. pylori infection in HIV-positive patients regardless of ART status in a high-burden setting
Abstract
Background
There is a widespread co-infection of HIV and Helicobacter pylori (H. pylori) globally, particularly in developing countries, an...
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Background: HIV rapid diagnosis in The Gambia is mainly done using Determine HIV-1/2 and First Response HIV 1.2.0 or SD Bioline HIV-1/2 3.0 for screening and sero-typing of HIV res...

